Get the Stockscreener App
4.73
5.40%
-0.27
After Hours:
4.65
-0.08
-1.69%
Acurx Pharmaceuticals Inc stock is traded at $4.73, with a volume of 57,180.
It is down -5.40% in the last 24 hours and up +10.26% over the past month.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
See More
Previous Close:
$5.00
Open:
$4.895
24h Volume:
57,180
Relative Volume:
0.12
Market Cap:
$7.50M
Revenue:
-
Net Income/Loss:
$-14.58M
P/E Ratio:
-4.113
EPS:
-1.15
Net Cash Flow:
$-9.80M
1W Performance:
-5.78%
1M Performance:
+10.26%
6M Performance:
-33.29%
1Y Performance:
-87.35%
1-Day Range:
$4.51
$4.9121
1-Week Range:
$4.51
$5.59
52-Week Range:
$3.80
$38.00
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
Name
Acurx Pharmaceuticals Inc
Sector
Industry
Phone
917-533-1469
Address
259 LIBERTY AVENUE, STATEN ISLAND
Compare ACXP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
4.73 | 10.41M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Acurx Pharmaceuticals Inc Stock (ACXP) Latest News
How resilient is Acurx Pharmaceuticals Inc. stock in market downturnsJuly 2025 Final Week & Reliable Momentum Entry Alerts - newser.com
Is Acurx Pharmaceuticals Inc. (3ZO) stock overpriced at current multiplesMarket Growth Review & Free AI Powered Buy and Sell Recommendations - newser.com
How strong is Acurx Pharmaceuticals Inc. (3ZO) stock earnings growthJuly 2025 Review & Long Hold Capital Preservation Plans - newser.com
What is the fair value of Acurx Pharmaceuticals Inc. stock nowWeekly Stock Summary & Daily Volume Surge Signals - newser.com
Will Acurx Pharmaceuticals Inc. stock split attract more investorsQuarterly Performance Summary & Fast Moving Market Watchlists - newser.com
Can swing trading help recover from Acurx Pharmaceuticals Inc. lossesPortfolio Value Report & Technical Pattern Alert System - newser.com
Can Acurx Pharmaceuticals Inc. stock maintain operating marginsJuly 2025 Setups & Safe Capital Allocation Plans - newser.com
Multi factor analysis applied to Acurx Pharmaceuticals Inc.Trade Volume Report & Risk Controlled Stock Pick Alerts - newser.com
Quantitative breakdown of Acurx Pharmaceuticals Inc. recent moveJuly 2025 Closing Moves & AI Powered Buy/Sell Recommendations - newser.com
Can Acurx Pharmaceuticals Inc. stock attract ESG capital inflowsWeekly Stock Recap & Real-Time Volume Analysis - newser.com
Why Acurx Pharmaceuticals Inc. stock appeals to analystsJuly 2025 Patterns & Entry and Exit Point Strategies - newser.com
Is Acurx Pharmaceuticals Inc. stock recession proofOptions Play & Community Driven Trade Alerts - newser.com
Is Acurx Pharmaceuticals Inc. stock a top momentum play2025 Price Action Summary & Fast Gain Swing Alerts - fcp.pa.gov.br
What risks investors should watch in Acurx Pharmaceuticals Inc. stockEarnings Overview Summary & Consistent Return Strategy Ideas - newser.com
Combining price and volume data for Acurx Pharmaceuticals Inc.July 2025 Macro Moves & Daily Growth Stock Tips - newser.com
Is this a good reentry point in Acurx Pharmaceuticals Inc.2025 Top Decliners & AI Based Buy and Sell Signals - newser.com
Can Acurx Pharmaceuticals Inc. stock sustain free cash flow growthChart Signals & Momentum Based Trading Ideas - newser.com
Will Acurx Pharmaceuticals Inc. stock outperform growth indexes2025 Analyst Calls & Technical Pattern Alert System - newser.com
Pattern recognition hints at Acurx Pharmaceuticals Inc. upsideQuarterly Earnings Report & Entry and Exit Point Strategies - newser.com
What dividend safety score for Acurx Pharmaceuticals Inc. stockAnalyst Downgrade & Free Long-Term Investment Growth Plans - newser.com
How to interpret RSI for Acurx Pharmaceuticals Inc. stockMarket Trend Report & Long-Term Capital Growth Ideas - newser.com
Will Acurx Pharmaceuticals Inc. (3ZO) stock draw ESG focused fundsMarket Movement Recap & Free Low Drawdown Momentum Trade Ideas - newser.com
Can Acurx Pharmaceuticals Inc. stock sustain market leadershipEntry Point & High Conviction Buy Zone Picks - newser.com
How supply shortages influence Acurx Pharmaceuticals Inc. (3ZO) stockQuarterly Trade Report & Proven Capital Preservation Methods - newser.com
Acurx Pharmaceuticals Inc Stock Analysis and ForecastEmerging Market Stocks & Low Cost Wealth Investment - earlytimes.in
Acurx Pharmaceuticals Inc Stock (ACXP) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):